Skip to content

Clinical trials

Phase 3 Musculoskeletal Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Phase: Phase 3 Country / region: Netherlands Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20121
20173
20211
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Amgen1
Avidity Biosciences, Inc.1
Calcilytix Therapeutics, Inc., a BridgeBio company1
Fulcrum Therapeutics1
Genzyme, a Sanofi Company1
Kyntra Bio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases9
Arthritis3
Joint Diseases3
Muscular Diseases3
Muscular Dystrophies3
Neuromuscular Diseases3
Arthritis, Psoriatic2
Genetic Diseases, Inborn2
Muscular Disorders, Atrophic2
Muscular Dystrophy, Duchenne2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.